[Clinical practice guidelines for systemic lupus erythematosus: Recommendations for general clinical management]

Med Clin (Barc). 2016 May 6;146(9):413.e1-14. doi: 10.1016/j.medcli.2016.01.013. Epub 2016 Mar 11.
[Article in Spanish]


Systemic lupus erythematosus (SLE) is a complex rheumatic multisystemic disease of autoimmune origin with significant potential morbidity and mortality. It is one of the most common autoimmune diseases with an estimated prevalence of 20-150 cases per 100,000 inhabitants. The clinical spectrum of SLE is wide and variable both in clinical manifestations and severity. This prompted the Spanish Ministry of Health, Social Services and Equality to promote and fund the development of a clinical practice guideline (CPG) for the clinical care of SLE patients within the Programme of CPG in the National Health System which coordinates GuiaSalud. This CPG is is intended as the reference tool in the Spanish National Health System in order to support the comprehensive clinical management of people with SLE by all health professionals involved, regardless of specialty and level of care, helping to standardize and improve the quality of clinical decisions in our context in order to improve the health outcomes of the people affected. The purpose of this document is to present and discuss the rationale of the recommendations on the general management of SLE, specifically, clinical follow-up, general therapeutic approach, healthy lifestyles, photoprotection, and training programmes for patients. These recommendations are based on the best available scientific evidence, on discussion and the consensus of expert groups.

Keywords: Clinical practice guidelines; Consenso; Consensus; Guía de práctica clínica; Lupus eritematoso sistémico; Systemic lupus erythematosus.

Publication types

  • Consensus Development Conference
  • Practice Guideline

MeSH terms

  • Aftercare / methods
  • Combined Modality Therapy
  • Disease Progression
  • Health Promotion
  • Humans
  • Immunosuppressive Agents / therapeutic use
  • Lupus Erythematosus, Systemic / therapy*
  • National Health Programs
  • Spain


  • Immunosuppressive Agents